Czech and Slovak Pharmacy - Issue 6/2023
Review Articles
256
267
Brief insight into the in silico properties, structure–activity relationships and biotransformation of fruquintinib, an anticancer drug of a new generation containing a privileged benzofuran scaffold
Dominika Nádaská, Lucia Hudecova, Gustáv Kováč, Ivan Malík
Original Articles
277
Potential impact on mental health in patients with treatment-resistant schizophrenia – clozapine augmentation with long-acting parenteral antipsychotics: a case series
M. Nováková, T. Hammer, E. Nováková, M. Mayerová, L. Ustohal, PharmDr. Bc. Hana Kotolová, Ph.D.
287
Prospects of сomplex pharmaceutical composition application for pharmacological correction of metabolic syndrome
Kateryna Kalko, Nadia Dukhnich, Oksana Mishchenko, Viktor Khomenko, Olena Toziuk
297
Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndrome
Lyudmila Kravchenko, Liana Unhurian, Svetlana K Tiuzhinska, Yana Ivanova, Maya Obrazenko, Liudmyla Zahorodnya, Tetiana Yamilova
304
Analysis of medication administration in relation to food and beverages in inpatients
Ondřej Tesař, Josef Malý, Lucie Malečová, Kateřina Malá-Ládová, Martin Doseděl, Iva Brabcová, Martin Červený, Radka Prokešová, Hana Hajduchová, Ivana Chloubová, Valérie Tóthová, Jiří Vlček
History of Pharmacy
312
On the history and development of some changes in pharmacy practice – work safety in pharmacies
Jozef Kolář, Tünde Ambrus
317
Beauty in books: pharmaceutical bookplates in the territory of the present Czech Republic
Ladislav Svatoš, Ladislava Valášková
Czech and Slovak Pharmacy
2023 Číslo 6
Najčítanejšie v tomto čísle
- Analysis of medication administration in relation to food and beverages in inpatients
- Ethical aspects of conducting clinical trials of human medicinal products
- Potential impact on mental health in patients with treatment-resistant schizophrenia – clozapine augmentation with long-acting parenteral antipsychotics: a case series
- Brief insight into the in silico properties, structure–activity relationships and biotransformation of fruquintinib, an anticancer drug of a new generation containing a privileged benzofuran scaffold